INTERNATIONAL PATENT: SHANGHAI VITALGEN BIOPHARMA CO., LTD. FILES APPLICATION FOR "TARGETING PRKAR2B TO ENHANCE BETA-ISLET FUNCTION AND SURVIVAL FOR TREATMENTS OF DIABETES"

GENEVA, Jan. 12 -- SHANGHAI VITALGEN BIOPHARMA CO., LTD. (Building 2, No.11 Jialilue RoadPudong New Area, Shanghai 201210) filed a patent application (PCT/CN2025/107151) for "TARGETING PRKAR2B TO ENHANCE BETA-ISLET FUNCTION AND SURVIVAL FOR TREATMENTS OF DIABETES" on Jul 04, 2025. With publication no. WO/2026/008066, the details related to the patent application was published on Jan 08, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): QU, Su (Building 2, No.11 Jialilue RoadPudong New Area, Shanghai 201210), TIAN, Shin-shay (Building 2, No.11 Jialilue RoadPudong New Area, Shanghai 201210), ZHA...